Demetrix Revenue and Competitors
Estimated Revenue & Valuation
- Demetrix's estimated annual revenue is currently $9M per year.
- Demetrix's estimated revenue per employee is $273,600
- Demetrix's total funding is $61M.
- Demetrix has 33 Employees.
- Demetrix grew their employee count by -68% last year.
Demetrix Competitors & AlternativesAdd Company
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Demetrix?
Demetrix is named after Demeter, the Greek goddess of the harvest. Nature is our source and our inspiration. Many of today's medicines are derived from nature. Evolution has devised exquisite chemistry to produce compounds that interact with us, and our pathogens, with pin-point accuracy. Demetrix is harvesting billions of years of evolution to make the best, natural medicines in a smart and responsible way. Demetrix brings together world-class expertise to produce nature's medicines through fermentation. We work hard to find the best of nature's medicines and understand the genes that produce them. Then we carefully introduce those genes into domesticated microbes to make our medicines available to all who need them. Demetrix was founded in 2017 in the San Francisco Bay Area by esteemed bioengineer Jay Keasling and renowned biologist William Haseltine. We are honored to be backed by Horizons Ventures.keywords:N/A
Number of Employees
Employee Growth %
Demetrix recently announced commercial production of a rare cannabinoid, along with a partnership with ingredient supplier Evonik.
Demetrix Bio. Dreamstime Xxl 226350748. Research and Markets projects the U.S. market for minor cannabinoidsincluding cannabigerol (CBG),...
Demetrix is a biotechnology company that believes in the power of science to make the world a better place. The company produces health and...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|